Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-11-24$0.99/sh+10,000$9,900→ 1,334,289 total(indirect: See Footnote) - Purchase
Common Stock
2025-11-25$0.98/sh+15,000$14,700→ 1,349,289 total(indirect: See Footnote)
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.